Live intraday price
Compare with our price levels
Close 2026-09-30: $149.18 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)
Price reached target T1 · 1 whale recently bought
🎯 Trade plan by price level
Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks
Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated
Risk : reward 1 : 4.3Moves ~$8.61 a day
⚖️ Positives and risks
- ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
- ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
- ●เพิ่งเกิด Golden Cross (MA50 ตัดขึ้น MA200)
- ●แข็งแกร่งกว่าตลาด (S&P 500) +170% ใน 6 เดือน
- ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
- ●รายได้โต +26% เทียบปีก่อน
- ●ราคาแตะจุดขาย T1 แล้ว (แนวต้าน)
- ●RSI 91 ซื้อมากเกินไป (Overbought) เสี่ยงย่อตัว
- ●ราคาห่างเหนือ MA200 ถึง +104% วิ่งมาไกลแล้ว
- ●ราคาเกินเป้าหมายนักวิเคราะห์เฉลี่ย 97.40 แล้ว (-35%)
- ●บริษัทยังขาดทุน (อัตรากำไรสุทธิติดลบ)
🕯️ Price chart
Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold
🐋 Whales holding this stock
From each whale's latest quarterly filing
📊 Past earnings and price reaction
Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days
Actual EPS -$1.34 · est. -$2.43 · After close
Day 1
Next 20 days
Actual EPS -$1.37 · est. -$1.96 · After close
Day 1
Next 20 days
Actual EPS -$2.44 · est. -$2.53 · After close
Day 1
Next 20 days
Actual EPS -$2.46 · est. -$3.26 · After close
Day 1
Next 20 days
Actual EPS -$3.18 · est. -$3.56 · After close
Day 1
Next 20 days
Actual EPS -$3.10 · est. -$3.80 · After close
Day 1
Next 20 days
Actual EPS -$2.89 · est. -$4.97 · After close
Day 1
Next 20 days
Actual EPS -$3.50 · est. -$6.43 · After close
Day 1
Next 20 days
Listen to the earnings call or read the full report on GRAL's investor relations page ↗ · Earnings data from Yahoo Finance
💬 User reviews
Rate and review this stock (sign-in required) — reviews don't affect the system's scores
Loading…
Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person
📰 Latest news
Here's Why Grail Stock Surged 55% This Week
Motley Fool · 2026-09-25
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
Stocktwits · 2026-09-25
GRAIL (GRAL) Wins FDA Panel Backing, Is It Now Overvalued?
Simply Wall St. · 2026-09-24
Grail Surges After FDA Advisors Back Its Cancer-Finding Blood Test
Investor's Business Daily · 2026-09-24
Dow Jones Futures Fall As Treasury Yields, Oil Prices Keep Rising. Meta, Everpure, Grail Are Early Movers.
Investor's Business Daily · 2026-09-24
🔬 Deep dive
For those who want the detailed numbers